DOI: 10.1055/s-00023610

Drug Research

Issue 09 · Volume 69 · September 2019 DOI: 10.1055/s-009-43977

Review

  • 471
    Hawash, Mohammed:

    Highlights on Specific Biological Targets; Cyclin-Dependent Kinases, Epidermal Growth Factor Receptors, Ras Protein, and Cancer Stem Cells in Anticancer Drug Development

    • Original Article

  • 479
    Takeuchi, Mitsuaki; Okamoto, Masayuki; Tamura, Miyuki; Murase, Takayo; Watanabe, Nobuhide:

    Pharmacokinetic Study of SKL-18287, a Novel Long-Acting Glucagon-Like Peptide-1 Receptor Agonist, in Rats, Monkeys and Mini-Pigs

  • 487
    Sridharan, Kannan; Sivaramakrishnan, Gowri:

    Vasoactive Agents for the Management of Variceal Bleeding: A Mixed Treatment Comparison Network Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials

    Supporting Information (PDF)
  • 496
    Danafar, Hossein; Asadi, Farnaz; Sharafi, Ali; Manjili, Hamidreza Kheiri:

    Preparation and Evaluation of pH Sensitive Novel Anticancer Drug Carrier Based on Magnetic Chitosan Quartets

  • 505
    Dittakavi, Sreekanth; Jat, Rakesh Kumar; Mullangi, Ramesh:

    Quantitation of Ivosidenib, A Novel Mutant IDH1 Inhibitoron Mice DBS: Application to a Pharmacokinetic Study

    • Opinion Paper

  • 512
    Nemer, Georges; Khalil, Athar:

    A Cautious Note on Thalidomide Usage in Cancer Treatment: Genetic Profiling of the TBX2 Sub-Family Gene Expression is Required